Target intelligence / Profile preview

Gastrointestinal hormone

Molecular classification
Other (peptide hormones; not a single molecule or receptor)
01

Overview

"Gut hormones" is an umbrella term referring to a diverse group of peptide and protein hormones secreted by specialized endocrine cells throughout the gastrointestinal tract. These molecules are not themselves therapeutic targets but rather represent an entire class that includes many distinct entities such as gastrin, cholecystokinin, secretin, glucagon-like peptide 1 (GLP‑1), glucose-dependent insulinotropic polypeptide (GIP), ghrelin, somatostatin, motilin, peptide YY (PYY), oxyntomodulin, among others[1][4][6][8]. Each member has unique receptors and biological actions. Gut hormones regulate essential physiological processes including digestion, nutrient absorption, appetite control, gastric acid secretion, pancreatic enzyme release, and overall energy homeostasis[4][8]. They act via endocrine, paracrine or neurocrine pathways depending on the specific molecule[6]. While several individual gut hormones or their receptors are considered important drug targets—especially in metabolic diseases like obesity and diabetes—the term "gut hormones" itself does not refer to any single molecular target or receptor. Therefore it is not appropriate for structured data extraction as if it were one target. Instead, each constituent should be treated separately for detailed pharmacological profiling. There is something incorrect with using "gut hormones" as a molecular target because it refers collectively to many different molecules rather than one defined entity suitable for drug targeting or biomarker development[1][4].

Other names
Gut hormoneGI hormoneEnteric hormoneDigestive hormone
02

Mechanism of action

null (as a group; mechanisms are specific to each individual gut hormone and its receptor)

03

Biological functions

Regulation of digestionControl of appetite and satietyModulation of gastrointestinal motilityStimulation/inhibition of gastric acid secretionRegulation of pancreatic enzyme secretion
04

Disease associations

ObesityDiabetes mellitusNon-alcoholic fatty liver disease (NAFLD)

Beyond the preview

Go deeper on Gastrointestinal hormone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastrointestinal hormone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call